Anzeige
Mehr »
Login
Mittwoch, 06.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
3.395 Leser
Artikel bewerten:
(2)

RedHawk Holdings Corp.: Sheriff Bud Torres III To Lead RedHawk's First Responder Marketing Unit

Torres is a 40-year Law Enforcement Veteran

LAFAYETTE, LA / ACCESSWIRE / April 8, 2020 / RedHawk Holdings Corp. (OTC PINK:SNDD) ("RedHawk" or the "Company"), a diversified holding company primarily engaged in sales and distribution of medical devices, announced today that it has named Sheriff Beauregard "Bud" Torres III ("Sheriff Torres"), a 40-year veteran of law enforcement, to lead the Company's First Responder marketing efforts.

Sheriff Torres is expected to join the Company's marketing team on July 1, 2020, upon the conclusion of his term as the Sheriff of Louisiana's Pointe Coupee Parish. Sheriff Torres has been the elected Sheriff of Pointe Coupee Parish since 2008 and has been responsible for supervising 100 law enforcement employees and managing a $12 million annual budget. During his tenure, he accrued a $19 million budget surplus while increasing the number of deputies and improving salaries and benefits. Prior to being elected the Sheriff of Pointe Coupee Parish, Sheriff Torres worked for 25 years with the Louisiana State Police including a ten-year assignment with the FBI Task Force for organized crime and narcotics enforcement. When Sheriff Torres retired from the Louisiana State Police, he was the Group Supervisor for the Baton Rouge, Louisiana Narcotics Field Office. He is currently a member of the National Sheriff's Association, the Louisiana Sheriff's Association, the Louisiana State Trooper Association and a member of the board of directors for the Louisiana Commission on Law Enforcement, the Louisiana Police Officer Standards and Training and the Greater Baton Rouge Capital District Law Enforcement Training Council.

Commenting on the appointment of Sheriff Torres, G. Darcy Klug, RedHawk's Chairman and Interim Chief Executive Officer, said, "We are truly excited to have Sheriff Torres join our marketing team. His vast experience and extensive list of associates throughout the law enforcement community will afford us a tremendous opportunity to introduce our medical devices to the many law enforcement agencies across the country."

About RedHawk Holdings Corp.

RedHawk Holdings Corp., formerly Independence Energy Corp., is a diversified holding company which, through its subsidiaries, is engaged in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. Through its medical products business unit, the Company sells the Sharps and Needle Destruction Device (SANDD™), WoundClot Surgical - Advanced Bleeding Control, and the Carotid Artery Digital Non-Contact Thermometer. Through our United Kingdom-based subsidiary, we manufacture and market branded generic pharmaceuticals. RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System, a unique, closed cabinet, nominal dose transmission full-body x-ray scanner. For more information, please visit: http://www.redhawkholdingscorp.com

Cautionary Statement Regarding Forward-Looking Statements

This release may contain forward-looking statements. Forward-looking statements are all statements other than statements of historical fact. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. The words "anticipate," "may," "can," "plans," "believes," "estimates," "expects," "projects," "targets," "intends," "likely," "will," "should," "to be," "potential" and any similar expressions are intended to identify those assertions as forward-looking statements.

Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties, including risks and uncertainties related to economic conditions and changes in market conditions. In evaluating forward-looking statements, you should consider the various factors which may cause actual results to differ materially from any forward-looking statements including those listed in the "Risk Factors" section of our latest 10-K report. Further, the Company may make changes to its business plans that could or will affect its results. Investors are cautioned that the Company will undertake no obligation to update any forward-looking statements.

Company Contact:

G. Darcy Klug, Chairman, CEO and CFO
(337) 269-5933
darcy.klug@redhawkholdingscorp.com

Investor Relations:

Stephanie Prince, Managing Director
PCG Advisory
(646) 762-4518
sprince@pcgadvisory.com

Media Contact:

Valerie Allen
Valerie Allen Public Relations
(310) 382-7800
valerie@valerieallenpr.com

SOURCE: RedHawk Holdings Corp.



View source version on accesswire.com:
https://www.accesswire.com/584362/Sheriff-Bud-Torres-III-To-Lead-RedHawks-First-Responder-Marketing-Unit

© 2020 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.